BioCentury This Week cover image

Ep. 121 - ASCO, CRISPR IP & CStone

BioCentury This Week

00:00

The House Energy and Commerce Bill Is Teed Up for a Vote of the Full House

The hope at fta and in regulated industry is that they will get this passed relatively quickly. If it doesn't, then at some point fda i's going to have to notify thousands of employees that their jobs are potentially at risk. And lastly, our colleague, paul benanos, has a story out on g s k's acquisition of atinvax for two point one million dollars.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app